Ironwood Pharmaceuticals | IRWD - Actif À Court Terme





Actif À Court Terme Changement Date
Acadia Pharmaceuticals USD 1.06B 14.31M 2025-12
Agios Pharmaceuticals USD 834.84M 107.21M 2026-03
Akebia Therapeutics USD 252.96M 5.38M 2025-12
Almirall EUR 713.98M 69K 2025-12
Alnylam Pharmaceuticals USD 4.22B 168.65M 2026-03
Amarin USD 626.02M 23.87M 2026-03
Ardelyx USD 381.87M 447K 2026-03
Astellas Pharma JPY 1.42T 19.35B 2026-03
AstraZeneca USD 29.61B 890M 2026-03
Charles River Laboratories USD 1.45B 85.06M 2025-12
Coherus Biosciences USD 206.71M 254.25M 2025-12
Emergent BioSolutions USD 679.5M 41.3M 2023-12
Esperion Therapeutics USD 462.57M 102.11M 2025-12
Halozyme Therapeutics USD 825.21M 503.54M 2025-12
Incyte USD 5.48B 460.36M 2026-03
Ironwood Pharmaceuticals USD 273.84M 82.09M 2025-09
Karyopharm Therapeutics USD 103.15M 13.4M 2025-12
Lexicon Pharmaceuticals USD 101.9M 20.63M 2025-12
MacroGenics USD 219.94M 12.15M 2025-12
Moderna USD 5.77B 774M 2026-03
Myriad Genetics USD 332.6M 12.2M 2025-12
Pacira USD 514.96M 33.01M 2026-03
PTC Therapeutics USD 2.27B 266.14M 2025-12
Puma Biotechnology USD 143.58M 7M 2025-09
Sarepta Therapeutics USD 2.54B 184.37M 2025-12
Takeda JPY 3.12T 195.82B 2025-12
Ultragenyx Pharmaceutical USD 951M 307.79M 2025-12
Vanda Pharmaceuticals USD 347.26M 20.23M 2025-12